Uroalerts Men's Health Weekly

January 06, 2026

Videos

Peer-to-Peer Clinical Conversations

Bladder-Centric Focus in BPH: Early Triage and a Five-Stage Model - Wayne Kuang

Wayne Kuang discusses his ManVsProstate initiative with Alan Wein, emphasizing bladder health preservation in BPH.

Preoperative Urinary Retention and Its Effect on HoLEP Surgery Outcomes - Diana Lopategui

Alan Wein hosts Diana Lopategui to present a retrospective database analysis examining whether chronic urinary retention severity impacts HoLEP outcomes.

Beyond the Abstracts

A Critical Analysis of the Methodological Limitations in Trials of Low-Intensity Shockwave Therapy for Erectile Dysfunction - Beyond the Abstract

Making Waves: An Update on Aquablation - Beyond the Abstract

Articles

Editor Selected Abstracts and Commentaries

Male Infertility

The Impact of Chlamydia trachomatis on Male Infertility: A Systematic Review and Meta-Analysis.

Is male infertility an early warning of more serious diseases?

Genetic diversity of infertile males in India.

CD43 expressed in Sertoli, Leydig and germ cells inhibits testicular function and represents a potential target to treat male infertility or effect male contraception.

Peyronie's Disease

Targeting the acute phase of Peyronie's disease: preliminary experience with Perovial®, a novel hyaluronic acid formulation.

Erectile Dysfunction

Erectile dysfunction and cardiovascular-kidney-metabolic syndrome: Insights from the all of us research program.

Exploring Patient Pathways and Care Situations in Men With Erectile Dysfunction in Different PDE-5 Inhibitor Regulatory Settings.

BPH - Benign Prostatic Enlargement

Risk of BPH-LUTS according to the PM₁₀ exposure: A longitudinal nationwide cohort-based study.

Assessment of miRNA 106a-5p and 375-3p Expression in the Context of the Wnt/β-Catenin Pathway-Comparison of Prostate Adenocarcinoma and Benign Prostatic Hyperplasia Tissues.

Pine-Extracted Phytosterol β-Sitosterol (APOPROSTAT® Forte) Inhibits Both Human Prostate Smooth Muscle Contraction and Prostate Stromal Cell Growth, Without Cytotoxic Effects: A Mechanistic Link to Clinical Efficacy in LUTS/BPH.

Complication Profile and Safety Outcomes of Aquablation in the Management of BPH.

Prostate Artery Embolization vs. Holmium Laser Enucleation of the Prostate: A Matched Pair Analysis of Functional Outcomes and Complications.

Penile & Urethral Cancers

Comprehensive review of penile cancer using MR imaging.

IL-12 as a Potential Prognostic Marker in Penile Cancer: Implications for Immune Dysregulation.

Testicular Cancer

Sex steroid hormones, gonadotropins and risk of testicular germ cell tumors: results from the STEED study.

Impact of insurance status on testicular cancer outcomes: A single-institution, dual-site study.

Postchemotherapy phenotypes of GCNIS-derived testicular germ cell tumors, focusing on yolk sac tumor variants, trophoblastic tumors, and somatic-type malignancies.

Prostate Cancer

Results of the Randomized Phase 3 AFU-GETUG-20 Trial Evaluating Adjuvant Leuprorelin Acetate After Radical Prostatectomy in Men with High-risk Localized Prostate Cancer.

Ultrahypofractionated Versus Conventionally Fractionated Whole-pelvis Radiotherapy in Prostate Cancer: A Randomized Clinical Trial.

Measurement of patients' acceptable symptom levels and priorities for symptom improvement in advanced prostate cancer.

The effects of prostate volume and PI-RADS category on optimal PSA-density thresholds for biopsy decision-making.

Long-term Functional Outcomes and Decision Regret after Robot-assisted Radical Prostatectomy: An Experienced Surgeon Series.

FDA Grants Regular Approval to Rucaparib for Metastatic Castration-Resistant Prostate Cancer

Quantifying the Impact of Biochemical Recurrence After Radical Prostatectomy on Overall Mortality by Years of Life Lost: Results from the SEARCH Database.

Comparison of Results from the BARCODE1 Study and Contemporary Prostate Cancer Screening Trials.

Assessing body composition using auto-segmentations of muscle and subcutaneous adipose tissue in prostate cancer patients receiving magnetic resonance-guided radiotherapy.

Assessment of quality control and effect of radiolysis on the in vivo biodistribution of [177Lu]Lu-PSMA-I&T.

Comparison of Prostate-Specific Antigen Response in Black Patients with Metastatic Castration-Sensitive Prostate Cancer Initiated on Apalutamide vs Abiraterone Acetate.

Geometry-encoded deep learning (GeoDL) framework for real-time 3D dose verification for online adaptive radiotherapy.

Nivolumab plus docetaxel versus placebo plus docetaxel for androgen receptor pathway inhibitor-pretreated and chemotherapy-naive metastatic castration-resistant prostate cancer (CheckMate 7DX): a double-blind, randomised, phase 3 trial.

Effects of Prior Local Therapy by Radical Prostatectomy or Radiotherapy on the Efficacy and Quality of Life of Patients Treated With Darolutamide in ARAMIS.

Incorporating physicians' contouring style into auto-segmentation of clinical target volume for post-operative prostate cancer radiotherapy using a language encoder.

The Olive Phenolic S-(-)-Oleocanthal as a Novel Intervention for Neuroendocrine Prostate Cancers: Therapeutic and Molecular Insights.

Prostate cancer-related genetic counseling in a safety-net healthcare setting.

Final Results of the Randomised Phase 2 Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer (ARNEO).

Benefit of prophylactic pelvic irradiation in intermediate-risk prostate cancer: A multicenter retrospective study (iPPAPI).

Prostate cancer screening.

PSMA PET-Positive Local Recurrences in the Prostate Bed Region and Their Coverage Based on Clinical Target Volume Delineation Guidelines from ESTRO-ACROP, PERYTON, FROGG, GFRU, and RTOG.

Radiomics-based machine learning models for predicting genomic alterations in metastatic prostate cancer using PSMA PET imaging: a pilot study.

EXTRA-PC: A phase II trial of masofaniten (EPI-7386) and enzalutamide for patients with treatment-naïve metastatic hormone-sensitive prostate cancer.

Advancements in artificial intelligence for prostate cancer: Optimizing diagnosis, treatment, and prognostic assessment.

Exercise, APOE Genotype, and Testosterone Modulate Gut Microbiome-Cognition Associations in Prostate Cancer Survivors.

Metabolomics of Prostate Cancer and Clinical Profiles Following Radiotherapy: Need for a Precision Phylometabolomics Approach.

Stereotactic Ablative Body Radiotherapy for PSMA-PET/CT Staged, Oligometastatic Prostate Cancer - A Multi-Centre Study - Beyond the Abstract

Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer after Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA Analysis - Beyond the Abstract

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2026 Digital Science Press, LLC